Author

J. Abel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

A. Dhoot· 1 shared A. Gessner· 1 shared A. J. Walter· 1 shared A. Khosla· 1 shared A. Mohr· 1 shared A. Prakash· 1 shared A. Taylor-Weiner· 1 shared B. Salzberger· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Dhoot

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell-type-specific nuclear morphology predicts genomic instability and prognosis in multiple cancer types

J. Abel, S. Jain, D. Rajan, H. Padigela, K. Leidal, A. Prakash, J. Conway, M. Nercessian, C. Kirkup, S. A. Javed, R. Biju, N. Harguindeguy, D. Shenker, N. Indorf, D. Sanghavi, , A. Taylor-Weiner

The paper develops a deep learning pipeline for nucleus segmentation and featurization in cancer histology, linking nuclear morphology to genomic instability and prognosis across multiple cancer types.

bioRxiv · May 15, 2023 · PreprintCancer Biology

IgG4 serum levels are not elevated in cases of Post-COVID syndrome

J. Abel, A. J. Walter, V. Glueck, C. L. Magnus, T. Glueck, P. Schuster, S. Blaas, I. Montanari, M. Koller, A. Mohr, T. Hinterberger, B. Salzberger, K. Renner, M. Mack, R. Bals, , D. Peterhoff

The paper compares IgG subtypes in Post-COVID patients and controls, finding no elevation in IgG4 but reduced IgG2, suggesting potential role of IgG2 in Post-COVID syndrome.

bioRxiv · Mar 1, 2023 · PreprintImmunology